122 related articles for article (PubMed ID: 9030857)
1. A boy with X-linked hyper-IgM syndrome and natural killer cell deficiency.
Ostenstad B; Giliani S; Mellbye OJ; Nilsen BR; Abrahamsen T
Clin Exp Immunol; 1997 Feb; 107(2):230-4. PubMed ID: 9030857
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization.
de Saint Basile G; Tabone MD; Durandy A; Phan F; Fischer A; Le Deist F
Eur J Immunol; 1999 Jan; 29(1):367-73. PubMed ID: 9933119
[TBL] [Abstract][Full Text] [Related]
3. De novo mutation causing X-linked hyper-IgM syndrome: a family study in Taiwan.
Ma YC; Lee WI; Shyur SD; Lin SC; Huang LH; Wu JY
Asian Pac J Allergy Immunol; 2005 Mar; 23(1):53-9. PubMed ID: 15997875
[TBL] [Abstract][Full Text] [Related]
4. [Neutropenia in patient with X-linked hyper-IgM syndrome].
Iwata M; Nunoi H; Nonoyama S; Shimadzu M; Higuchi S; Yanabe Y; Migita M; Adachi N; Matsuda I
Rinsho Ketsueki; 1995 Oct; 36(10):1223-9. PubMed ID: 8531335
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand and its role in X-linked hyper-IgM syndrome.
Callard RE; Armitage RJ; Fanslow WC; Spriggs MK
Immunol Today; 1993 Nov; 14(11):559-64. PubMed ID: 7506037
[TBL] [Abstract][Full Text] [Related]
6. CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome.
Notarangelo LD; Peitsch MC; Abrahamsen TG; Bachelot C; Bordigoni P; Cant AJ; Chapel H; Clementi M; Deacock S; de Saint Basile G; Duse M; Espanol T; Etzioni A; Fasth A; Fischer A; Giliani S; Gomez L; Hammarstorm L; Jones A; Kanariou M; Kinnon C; Klemola T; Kroczek RA; Levy J; Matamoros N; Monafo V; Paolucci P; Reznick I; Sanal O; Smith CI; Thompson RA; Tovo P; Villa A; Vihinen M; Vossen J; Zegers BJ
Immunol Today; 1996 Nov; 17(11):511-6. PubMed ID: 8961627
[TBL] [Abstract][Full Text] [Related]
7. A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome.
Lin Q; Rohrer J; Allen RC; Larché M; Greene JM; Shigeoka AO; Gatti RA; Derauf DC; Belmont JW; Conley ME
J Clin Invest; 1996 Jan; 97(1):196-201. PubMed ID: 8550833
[TBL] [Abstract][Full Text] [Related]
8. Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome.
Ameratunga R; Lederman HM; Sullivan KE; Ochs HD; Seyama K; French JK; Prestidge R; Marbrook J; Fanslow WC; Winkelstein JA
J Pediatr; 1997 Jul; 131(1 Pt 1):147-50. PubMed ID: 9255207
[TBL] [Abstract][Full Text] [Related]
9. Mutations of CD40 ligand in two patients with hyper-IgM syndrome.
García-Pérez MA; Paz-Artal E; Corell A; Moreno A; López-Goyanes A; García-Martín F; Vázquez R; Pacho A; Romo E; Allende LM
Immunobiology; 2003; 207(4):285-94. PubMed ID: 12952351
[TBL] [Abstract][Full Text] [Related]
10. Clinical spectrum of X-linked hyper-IgM syndrome.
Levy J; Espanol-Boren T; Thomas C; Fischer A; Tovo P; Bordigoni P; Resnick I; Fasth A; Baer M; Gomez L; Sanders EA; Tabone MD; Plantaz D; Etzioni A; Monafo V; Abinun M; Hammarstrom L; Abrahamsen T; Jones A; Finn A; Klemola T; DeVries E; Sanal O; Peitsch MC; Notarangelo LD
J Pediatr; 1997 Jul; 131(1 Pt 1):47-54. PubMed ID: 9255191
[TBL] [Abstract][Full Text] [Related]
11. A novel splice-site mutation in the CD40L gene in a patient with X-linked hyper-IgM syndrome.
Dezsö D; Orth U; Heilbronner H; Gal A
Hum Mutat; 1996; 7(2):181-2. PubMed ID: 8829642
[No Abstract] [Full Text] [Related]
12. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
13. Hyper-IgM immunodeficiency with disseminated cryptococcosis.
Iseki M; Anzo M; Yamashita N; Matsuo N
Acta Paediatr; 1994 Jul; 83(7):780-2. PubMed ID: 7949815
[TBL] [Abstract][Full Text] [Related]
14. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.
Bhushan A; Covey LR
Immunol Res; 2001; 24(3):311-24. PubMed ID: 11817328
[TBL] [Abstract][Full Text] [Related]
15. CD40 ligand/CD40 deficiency.
Castigli E; Fuleihan R; Ramesh N; Tsitsikov E; Tsytsykova A; Geha RS
Int Arch Allergy Immunol; 1995; 107(1-3):37-9. PubMed ID: 7542090
[TBL] [Abstract][Full Text] [Related]
16. The influence of CD40-CD154 interactions on the expressed human V(H) repertoire: analysis of V(H) genes expressed by individual B cells of a patient with X-linked hyper-IgM syndrome.
Brezinschek HP; Dörner T; Monson NL; Brezinschek RI; Lipsky PE
Int Immunol; 2000 Jun; 12(6):767-75. PubMed ID: 10837404
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation as treatment for X-linked immunodeficiency with hyper-IgM.
Bordigoni P; Auburtin B; Carret AS; Schuhmacher A; Humbert JC; Le Deist F; Sommelet D
Bone Marrow Transplant; 1998 Dec; 22(11):1111-4. PubMed ID: 9877275
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte transfusion-associated granulocyte responses in a patient with X-linked hyper-IgM syndrome.
Atkinson TP; Smith CA; Hsu YM; Garber E; Su L; Howard TH; Prchal JT; Everson MP; Cooper MD
J Clin Immunol; 1998 Nov; 18(6):430-9. PubMed ID: 9857288
[TBL] [Abstract][Full Text] [Related]
20. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
Conley ME; Larché M; Bonagura VR; Lawton AR; Buckley RH; Fu SM; Coustan-Smith E; Herrod HG; Campana D
J Clin Invest; 1994 Oct; 94(4):1404-9. PubMed ID: 7523449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
